<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3054">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04530461</url>
  </required_header>
  <id_info>
    <org_study_id>UR17DN02-002</org_study_id>
    <nct_id>NCT04530461</nct_id>
  </id_info>
  <brief_title>Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases</brief_title>
  <official_title>Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>faida agili</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>UR17DN02 : Autoimmune Diseases Research Unit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Military Hospital of Tunis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational study aiming to assess the serological profile of SARS-Cov2 patients with
      systemic diseases such as systemic lupus erythematosus, Sjogren syndrome, sarcoidosis,
      inflammatory myopathies, Behçet's disease, Rheumatoid arthritis and Spondyloarthritis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a prospective, observational, multicenter clinical trial to be conducted in the
      internal medicine, rheumatology and virology departments of Military Hospital of Tunis. After
      obtaining informed consent from the patient, the investigator will perform an inclusion visit
      made of a patient interview and performing blood sample to search for IgG and anti-SARS IgM
      CoV2.

      Patients with IgM-like antibodies will have an RT-PCR test for active infection. If the study
      participants will be diagnosed with COVID-19 positive during the study period, the attending
      physician is entitled to decide on their management based on the severity of the clinical
      status.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serological Profile</measure>
    <time_frame>Inclusion</time_frame>
    <description>Number of patients with positive serological test of SARS Cov2</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>SARS-CoV Infection</condition>
  <condition>Systemic Disease</condition>
  <condition>Systemic Lupus Erythematosus</condition>
  <condition>Sjogren's Syndrome</condition>
  <condition>Sarcoidosis</condition>
  <condition>Inflammatory Myopathy</condition>
  <condition>Behçet Disease</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Spondyloarthritis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serological test</intervention_name>
    <description>Positive serological test of SARS Cov2</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with one of the following conditions: systemic lupus, Sjögren's syndrome,
        rheumatoid arthritis, inflammatory myopathies, spondyloarthritis, sarcoidosis and Behçet's
        disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years old

          -  One of the following conditions: systemic lupus, Sjögren's syndrome, rheumatoid
             arthritis, inflammatory myopathies, spondyloarthritis, sarcoidosis and Behçet's
             disease.

          -  Informed consent obtained and signed

        Exclusion Criteria:

          -  Refusal to repeat blood sampling if the first one was badly performed

          -  Informed consent not obained
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faida Ajili, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Military Hospital of Tunis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Faida Ajili, MD</last_name>
    <phone>+21698631188</phone>
    <email>faida1977@yahoo.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Military Hospital of Tunis</name>
      <address>
        <city>Tunis</city>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faida Ajili, MD</last_name>
      <phone>+21698631188</phone>
      <email>faida1977@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Faida Ajili, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sameh Sayahi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rim Dhahri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 28, 2020</study_first_posted>
  <last_update_submitted>September 19, 2020</last_update_submitted>
  <last_update_submitted_qc>September 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Military Hospital of Tunis</investigator_affiliation>
    <investigator_full_name>faida agili</investigator_full_name>
    <investigator_title>Director of Autoimmune Diseases Research Unit (UR17DN02) and Professor in internal medicine departement. Sponsor and Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Myositis</mesh_term>
    <mesh_term>Behcet Syndrome</mesh_term>
    <mesh_term>Sarcoidosis</mesh_term>
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

